Prior evidence has indicated that GGCT plays a critical role in maintaining redox balance and prolonging lifespan in red blood cells via the regulation of GSH metabolism, providing a key clue for exploring the crosstalk between Gln and GGCT in cancer [31]
Compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, the aHR was 1.18 (95% CI
Maskey AR, Sasaki A, Sargen M, Kennedy M, Tiwari RK, Geliebter J, Safai B, Li XM
Early use helps achieve significant weight loss and improved metabolic outcomes, which can reduce the need for more invasive treatments later
This may explain some of its protective effects on various tissues
To put that in perspective, semaglutide (Wegovy) averages about 15% weight loss, and tirzepatide averages around 21%